Skip to content

We believe in more effective and affordable healthcare driven by a deeper understanding of a patient's disease

5. Endometriosis-01-min

Actionable insights for complex diseases

Our clinical decision support platform interprets mechanostic test results, creating personalized precision medicine reports based on the patient’s underlying disease mechanisms.

Reports include actionable insights, including:
 Patient's lifetime disease risk
 Disease-associated mechanisms with supporting evidence
 Associated symptoms
 Effective treatment recommendations 
 Eligible clinical trials for likely effective treatments

Maximize patient outcomes

Tailor care to disease mechanisms, ensuring proactive intervention, accurate triage, and effective treatment.

Reduce time and costs

Stop inaccurate referrals, ineffective prescriptions, and the progression of unmanaged disease.

Prevent chronic disease

Determine lifetime risk of disease and protect with targeted preventative medicines to delay onset and stop disease progression.

The only tool that converts a patient's disease mechanisms into actionable insights to predict, treat, and prevent chronic diseases

Identify disease risks early

The CDS identifies lifetime risks of disease, enabling earlier detection and proactive intervention before symptoms arise.



Triage patients accurately

The CDS differentiates complex conditions with overlapping symptoms, enabling accurate diagnoses and differential triage.



Predict disease trajectory

The CDS analyzes genetic mechanisms to predict disease progression, guiding personalized monitoring and care pathways.



Select the right treatment

The CDS can match therapies to individual genetic profiles, guiding precision treatments for better patient outcomes.

PrecisionLife clinical decision support-1
Actively protective drug targets

Seamless integration

Our clinical decision support system seamlessly deploys inside multiple HIPAA/GDPR protected clinical environments, integrating into existing workflows.



Trust & transparency

Our reports are based on a simple count of genotypic signatures identified by our mechnostic tests. There's no complex polygenic risk score models or black box AI – our findings are reproducible and explainable.

We remove the bias of machine learning software and avoid the main issues of concern to regulators around software interpretation and AI.

Simple workflow delivering actionable insights

Sample collection


Minimally invasive buccal swab or blood sample taken by the patient at home or in their primary care setting.

Genotyping & analysis


The sample is tested against a well-known genotyping array using industry standard equipment to generate a comprehensive genetic profile.

Mechanistic interpretation


Our clinical decision support platform interprets the results, identifying disease-associated mechanisms and generating a clear report for the clinician.

Disease risk & cause


Report predicts disease risk before symptoms appear and determine the causative mechanisms underpinning disease to personalize care.

Predict & prevent chronic diseases

Mechanostic precision medicine tests and actively protective therapies offer significant benefits - identifying people at risk, selecting effective interventions and enabling disease prevention - improving patient outcomes and reducing cost of care. 

Mechanostics®

Rapid, non-invasive tests to identify disease risk and guide therapy selection based on underlying disease mechanisms.

Actively Protective Biology

New class of drug targets that protect against the development of major chronic disease.

Let's talk

Patients are counting on us

We're helping more and more partners to achieve better health for patients, faster.

Contact us to find out more.